"The Cancer Institute unites physicians, nurses and researchers from the University of Mississippi Medical Center and the University of Mississippi in the quest to stop cancer through: Interdisciplinary world class cancer prevention, detection and treatment. Research to better prevent, detect and treat cancer. Education for Mississippi residents and the medical caregivers who one day will provide their cancer care. Adult and pediatric physicians see more than 2,000 new patients annually and follow more than 5,800 survivors. Cancer teams see many people with rare or complex care needs."

During the past decade, University of Mississippi Cancer Clinic conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 51 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 5 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Mississippi Cancer Clinic" #1 sponsor was "SWOG Cancer Research Network" with 28 trials, followed by "Children's Oncology Group" with 22 trials sponsored, "Alliance for Clinical Trials in Oncology" with 8 trials sponsored, "Gynecologic Oncology Group" with 7 trials sponsored and "Radiation Therapy Oncology Group" with 7 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Mississippi Cancer Clinic" #1 collaborator was "National Cancer Institute (NCI)" with 77 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator, "Eastern Cooperative Oncology Group" with 4 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator and "SWOG Cancer Research Network" with 4 trials as a collaborator. Other collaborators include 18 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "University of Mississippi Cancer Clinic" are "Breast Cancer" (10 trials), "Leukemia" (10 trials), "Lymphoma" (8 trials), "Lung Cancer" (7 trials) and "Prostate Cancer" (7 trials). Many other conditions were trialed in "University of Mississippi Cancer Clinic" in a lesser frequency.

Most popular intervention types in "University of Mississippi Cancer Clinic" are "Drug" (55 trials), "Radiation" (23 trials), "Other" (22 trials), "Biological" (21 trials) and "Procedure" (18 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (14 trials), "radiation therapy" (13 trials), "etoposide" (11 trials), "doxorubicin hydrochloride" (10 trials) and "cisplatin" (8 trials). Other intervention names were less common.

The vast majority of trials in "University of Mississippi Cancer Clinic" are 59 trials for "All" genders, 12 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "University of Mississippi Cancer Clinic". undefined are not yet recruiting, undefined are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 64 completed trials in University of Mississippi Cancer Clinic, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in University of Mississippi Cancer Clinic, 2 "Phase 1" clinical trials were conducted, 36 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".